Preclinical Investigation of Tian-Zhi-Kang as a Candidate Chemotherapeutic Agent

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/159/30/20

Funding

  • Changzhou Yujing BioTech Company LTD: $680,702.00